Renvela 2.4 GM Powder for Oral Suspension
RxNorm 861373
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 861373 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Renvela 2.4 GM Powder for Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Renvela 2.4 GM Powder for Oral Suspension
(Atom ID: 8262264)
SYPrescribable
Synonym (SY):
Renvela 2.4 GM Powder for Oral Suspension
(Atom ID: 8262266)
SYPrescribable
Synonym (SY):
Renvela 2400 mg Powder for Oral Suspension
(Atom ID: 8262265)
SBDPrescribable
Semantic Branded Drug (SBD):
Sevelamer carbonate 2400 mg Powder for Oral Suspension [Renvela]
(Atom ID: 8262263)
Patient Education
Sevelamer
Sevelamer is used to control high blood levels of phosphorus in people with chronic kidney disease who are on dialysis (medical treatment to clean the blood when the kidneys are not working properly). Sevelamer is in a class of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.
[Learn More]
* Please review the disclaimer below.